Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri P Mikhailidis

Showing results (471-480 of 675) with videos related to

Pageof 68
Sort By:
The Clinical Respiratory Journal|August 22, 2019
Increased risk for cardiovascular disease in patients with obstructive sleep apnoea syndrome-chronic obstructive pulmonary disease (overlap syndrome)Athanasios Voulgaris, Kostas Archontogeorgis, Nikolaos Papanas, et al.
Expert Opinion on Pharmacotherapy|October 12, 2007
Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?Vasilios G Athyros, Konstantinos Tziomalos, Dimitri P Mikhailidis, et al.
Expert Opinion on Therapeutic Targets|January 18, 2007
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?Asterios Karagiannis, Dimitri P Mikhailidis, Vasilios G Athyros, et al.
Neurological Research|April 22, 2010
Seasonal variation in the occurrence of stroke in Northern Greece: a 10 year study in 8204 patientsAsterios Karagiannis, Konstantinos Tziomalos, Dimitri P Mikhailidis, et al.
Expert Opinion on Pharmacotherapy|March 4, 2008
Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronismAsterios Karagiannis, Konstantinos Tziomalos, Athanasios Papageorgiou, et al.
Current Medical Research and Opinion|April 9, 2011
Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysisDimitri P Mikhailidis, Richard W Lawson, Anna-Louise McCormick, et al.
Vascular and Endovascular Surgery|April 25, 2012
Near-infrared spectroscopy assessment following exercise training in patients with intermittent claudication and in untrained healthy participantsFabio Manfredini, Anna Maria Malagoni, Simona Mandini, et al.
Current Vascular Pharmacology|May 1, 2013
Uric acid metabolism in pre-hypertension and the metabolic syndromeManfredi Rizzo, Milan Obradovic, Milica Labudovic-Borovic, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|July 31, 2020
Lipoprotein Apheresis and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia: A One Center StudyVana Kolovou, Niki Katsiki, Stamatis Makrygiannis, et al.
The Open Cardiovascular Medicine Journal|June 16, 2011
Cholesteryl ester transfer protein gene and effectiveness of lipid lowering of atorvastatinGenovefa Kolovou, Constantinos Mihas, Katherine Anagnostopoulou, et al.
Pageof 68

Showing results (471-480 of 675) with videos related to

Sort By:
Pageof 68
The Clinical Respiratory Journal|August 22, 2019
Increased risk for cardiovascular disease in patients with obstructive sleep apnoea syndrome-chronic obstructive pulmonary disease (overlap syndrome)Athanasios Voulgaris, Kostas Archontogeorgis, Nikolaos Papanas, et al.
Expert Opinion on Pharmacotherapy|October 12, 2007
Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?Vasilios G Athyros, Konstantinos Tziomalos, Dimitri P Mikhailidis, et al.
Expert Opinion on Therapeutic Targets|January 18, 2007
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?Asterios Karagiannis, Dimitri P Mikhailidis, Vasilios G Athyros, et al.
Neurological Research|April 22, 2010
Seasonal variation in the occurrence of stroke in Northern Greece: a 10 year study in 8204 patientsAsterios Karagiannis, Konstantinos Tziomalos, Dimitri P Mikhailidis, et al.
Expert Opinion on Pharmacotherapy|March 4, 2008
Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronismAsterios Karagiannis, Konstantinos Tziomalos, Athanasios Papageorgiou, et al.
Current Medical Research and Opinion|April 9, 2011
Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysisDimitri P Mikhailidis, Richard W Lawson, Anna-Louise McCormick, et al.
Vascular and Endovascular Surgery|April 25, 2012
Near-infrared spectroscopy assessment following exercise training in patients with intermittent claudication and in untrained healthy participantsFabio Manfredini, Anna Maria Malagoni, Simona Mandini, et al.
Current Vascular Pharmacology|May 1, 2013
Uric acid metabolism in pre-hypertension and the metabolic syndromeManfredi Rizzo, Milan Obradovic, Milica Labudovic-Borovic, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|July 31, 2020
Lipoprotein Apheresis and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia: A One Center StudyVana Kolovou, Niki Katsiki, Stamatis Makrygiannis, et al.
The Open Cardiovascular Medicine Journal|June 16, 2011
Cholesteryl ester transfer protein gene and effectiveness of lipid lowering of atorvastatinGenovefa Kolovou, Constantinos Mihas, Katherine Anagnostopoulou, et al.
Pageof 68